- Home
- MNSB vs ORMP Comparison
MNSB vs ORMP Comparison
Compare MNSB & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | ORMP |
|---|---|---|
| Founded | 2003 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 170.3M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MNSB | ORMP |
|---|---|---|
| Price | $24.39 | $4.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.7K | ★ 152.4K |
| Earning Date | 04-20-2026 | 05-14-2026 |
| Dividend Yield | 1.68% | ★ 6.51% |
| EPS Growth | 210.00 | ★ 412.50 |
| EPS | 1.05 | ★ 2.76 |
| Revenue | ★ $135,615,000.00 | $2,000,000.00 |
| Revenue This Year | $1.50 | N/A |
| Revenue Next Year | $3.77 | N/A |
| P/E Ratio | $23.32 | ★ $1.54 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $17.86 | $1.98 |
| 52 Week High | $25.29 | $5.19 |
Technical Indicators
Market Signals| Indicator | MNSB | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 50.65 |
| Support Level | $23.58 | $3.91 |
| Resistance Level | $25.16 | $4.22 |
| Average True Range (ATR) | 0.53 | 0.19 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 94.65 | 46.37 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.